CHM vs PKP

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CHM

CHIMERIC FPO [CHM]

32LOW

PKP

PEAK FPO [PKP]

32LOW

Score Breakdown

CHM PKP
Technical
58
47
Catalyst
55
51
Sentiment
50
50
Fundamental
6
27
Momentum
39
48
Risk Gate
27
27

Key Metrics

CHM Metric PKP
$8.8MMarket Cap$19.7M
8.4MAvg Volume (20d)2.0M
N/AShort InterestN/A
$0.00952-Week High$0.024
$0.00152-Week Low$0.014
+0.0%Daily Change+13.3%
$0.002Entry Price$0.017
-1291.0%ROEN/A
-192.7%Profit Margin-53.9%

Active Signals

CHM Signals

●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.2 quarters)
●Low P/S ratio (0.9x)
●Revenue in sharp decline (-53%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised downward (-10pts)

PKP Signals

●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Critical cash runway (0.3 quarters)
●Low P/S ratio (1.3x)
●Piotroski F-Score weak (2/9, low-confidence approx)
●Micro-cap ($5-20M) - high risk
●Large director buy detected (1 significant transactions)
●Capital raise activity (1 events)
●Deeply negative margins (-54%)

Ask Scout AI to compare CHM and PKP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CHM Full Analysis → PKP Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).